+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Future of Therapy: Technology Advances in Drug-device Combination Products

  • Report

  • 59 Pages
  • June 2020
  • Region: Global
  • Frost & Sullivan
  • ID: 5118841

Technology Innovations Driving Growth Opportunities such as Improving Device Performance and Medication Efficacy

Drug device combination products are aimed to provide targeted treatment, enable better drug delivery and improve the efficacy of the device and medicine. This research service (RS) showcases some of these emerging drug-device combination products including drug eluting stents and drug loaded /coated orthopedic implants under implantable drug-device combination and drug eluting lens and drug eluting bandages under non-implantable drug device combinations. The research service discusses the impact of these innovations, patents, technology roadmap and growth opportunities.

Table of Contents

1.0 Executive Summary
1.1 Scope of the Research
1.2 Research Methodology
1.3 Key Findings
2.0 Industry Overview
2.1 Drug-device Combination Products Improving Delivery of Drugs or Therapeutics Efficacy of the Device
2.2 Segmentation of Drug-device Combination Based on Product Type
2.3 Segmentation of Drug-device Combination Based on Application Type
2.4 Growth Opportunity: Drug-device Combinations Improving Performance of Medical Devices
2.5 Growth Opportunity: Drug-device Combination Improves Patients’ Acceptance of Medication
3.0 Drug-device Combination Product: Innovation Tracker
3.1 Innovations in Drug-eluting Stents
3.1.1 Drug-eluting Stent to Address the Challenge of in-stent Restenosis
3.1.2 Sirolimus-eluting Coronary Stent with Ultrathin Strut
3.1.3 Zotarolimus-eluting Coronary Stent System
3.1.4 Paclitaxel-eluting Vascular Stent System
3.1.5 Key Companies in Drug-eluting Stent Innovations
3.1.6 The US Leads Patent Activity for Drug-eluting Stents
3.1.7 Key Recent Patents in Drug-eluting Stents to Check
3.2 Innovations in Drug-eluting Contact Lens
3.2.1 Drug-eluting Lens Presenting Growth Opportunities to Replace Ocular Drug Delivery Systems
3.2.2 Drug-eluting Clear Corneal Bandage Lens
3.2.3 Antihistamine-releasing Contact Lens for Ocular Allergy
3.2.4 Digital Printed Drug Layers on Contact Lens for Glaucoma Therapy
3.2.5 Digital-eluting Lens for Treating Corneal Pathologies
3.2.6 Moderate to Low Patent Activity of Drug-eluting Contact Lens with Johnson & Johnson Vision Care Inc., Showing High Activity
3.2.7 Key Recent Drug-eluting Contact Lens Patents to Check
3.3 Innovations in Drug-eluting Bandages
3.3.1 Drug-eluting Wound Care Devices Provide Faster Healing and Eliminate Infections
3.3.2 Chitosan-based Wound Dressing for Hemostatic Effect
3.3.3 Kaolin-based Hemostatic Dressing for Emergency Medical Service
3.3.4 Antimicrobial Impregnated Wound Care Dressings to Avoid Wound Infections
3.3.5 Silver, Iodine, Copper Ions for Antimicrobial Activity in Wound Care Bandages
3.3.6 IP Activity of Drug Releasing Wound Care Bandages/Dressings
3.3.7 Key Recent Drug-eluting Kens Patents to Check
3.4 Drug-eluting Orthopedic Implant
3.4.1 Drug-eluting Orthopedic Implants Offering Better Osteointegration and Protection from Infection
3.4.2 Calcium Scaffold Carrying Antibiotic for Infection Management
3.4.3 Peptide-based Bone Graft for Faster Repair
3.4.4. Doxycycline-eluting Synthetic Bone Substitute
3.4.5 Key Research on Drug-coated Orthopedic Implants
3.4.6 Patent Activity of Drug-loaded Orthopedic Devices Dominated by the US Patents
3.4.7 Key Recent Drug Loaded Bone Scaffold Patents to Check
4.0 Emerging Technology Roadmap and Growth Opportunity
4.1 Emerging Technology Roadmap of Drug-eluting Stents (DES)
4.2 Future of Coronary Stents: Gene Eluting Stents to Overcome Restenosis and Late-stent Thrombosis Challenges
4.3 Drug-eluting Lens Envisions Sensor Technology Convergence into its Product
4.4 Smart Wound Dressing Including Sensor Technology Innovations
4.5 Nanotechnology to Improve the Regenerative Properties of Drug-eluting Bone Scaffold
4.6 Business Growth Opportunities - Patient Centric, Patient Specific, and Cost-effective Imaging Redefining Future of Therapy
4.7 Strategic Imperatives for the Future of the Drug-device Combination Products
5.0 Key Industry Contacts

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Johnson & Johnson
  • Vision Care Inc